In vitro and in vivo anticancer efficacy of the combination of Actinomycin D and resveratrol
{{output}}
Actinomycin D (Act D) was the first FDA-approved anticancer antibiotic. However, its widespread application was hindered by dose-limiting toxicities. In the current study, we investigated the in vitro and in vivo anticancer efficacy of the combination of Act D... ...
